Is Doximity Inc (DOCS) overvalued?
Doximity Inc (DOCS) is a health information services company listed on US.
This page asks whether Doximity Inc (DOCS) looks expensive on cached numbers — not a short thesis.
Latest reported DOCS revenue for 2025-03-31 was $570.4M. Net income was $223.2M. Revenue was up 20.0% from 2024-03-31 to 2025-03-31. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
DOCS currently screens at market cap $3.77B and trailing P/E 21.0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next DOCS 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the DOCS stock page for the full model, not this heading.
Not investment advice.